SS

Shital Sharad Khairnar

Active Director Designated Partner DIN 09280933
DIN 09280933 First appointment Aug 2021 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Shital Sharad Khairnar

Data last updated:

Shital Sharad Khairnar is a Designated Partner at Narvax Pharma Llp (since 2021). The company operates in Business Services.

DIN 09280933
Primary Designation Designated Partner
Industry Business Services
First Appointment 13 Aug 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Aug 20212021Active

Board colleagues of Shital Sharad Khairnar

NameDINCompanyDesignation
Amol Rajendra Bachhav06912002Narvax Pharma LlpDesignated Partner
Hitesh Murlidhar Metkar09280934Narvax Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Narvax Pharma Llp
Premium access

Shareholding and investment profile for Shital Sharad Khairnar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shital Sharad Khairnar

Shital Sharad Khairnar currently holds 1 directorship: Narvax Pharma Llp (Designated Partner, since 13 Aug 2021).

Shital Sharad Khairnar was first appointed on 13 Aug 2021 as Designated Partner at Narvax Pharma Llp.

The current boards of Shital Sharad Khairnar's companies include Amol Rajendra Bachhav (Narvax Pharma Llp), Hitesh Murlidhar Metkar (Narvax Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available